Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer now shows a revision label of v3.5.4, indicating a new release build.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.3) was added to the study record history, replacing the previous revision (v3.5.2). This reflects a platform/version update rather than any change to the trial content.
    Difference
    0.1%
    Check dated 2026-04-30T17:03:07.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-16T11:16:17.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a revision entry for v3.5.0 and removed the v3.4.3 entry from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T21:09:30.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 in the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:07.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1 from the history.
    Difference
    0.6%
    Check dated 2026-02-11T10:20:10.000Z thumbnail image

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.